Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study.

Shrestha S. et al, (2022), Lancet Glob Health, 10, e1494 - e1504

Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study.

Kandasamy R. et al, (2022), Lancet Microbe, 3, e503 - e511

Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease: Six-year Experience From a UK Children's Hospital

Bijker EM. et al, (2022), Pediatric Infectious Disease Journal, 41, 575 - 578

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.

Versteegen P. et al, (2022), Front Immunol, 13

Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.

Shrestha S. et al, (2021), J Infect Dis, 224, S267 - S274

Fatal tuberculous meningitis in an infant presenting with seizures in the UK.

Khambati N. et al, (2021), BMJ Case Rep, 14

Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers.

Gurung M. et al, (2021), Pediatr Infect Dis J

Corrigendum to 'Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom'.

Versteegen P. et al, (2021), EBioMedicine, 68

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.

Harwood R. et al, (2021), Lancet Child Adolesc Health, 5, 133 - 141

14-year trends and resistance patterns of blood and cerebrospinal fluid cultures in children under three years old

Takata J. et al, (2021), Journal of Infection

A computational method for immune repertoire mining that identifies novel binders from different clonotypes, demonstrated by identifying anti-pertussis toxoid antibodies.

Richardson E. et al, (2021), MAbs, 13

A public health ethic should inform policies on COVID-19 immunity passports - Authors' reply.

Brown RCH. et al, (2020), Lancet Infect Dis

Reply to Baylis and Kofler

BROWN R. et al, (2020), Lancet Infectious Diseases

The scientific and ethical feasibility of immunity passports.

Brown RCH. et al, (2020), Lancet Infect Dis

Principles of immunisation in children with solid organ transplant.

Kelgeri C. et al, (2020), Arch Dis Child

Inferring B cell specificity for vaccines using a Bayesian mixture model.

Fowler A. et al, (2020), BMC Genomics, 21

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.

Adams ER. et al, (2020), Wellcome Open Res, 5

Case Report: Disseminated, rifampicin resistant Mycobacterium bovis (BCG) infection in an immunocompromised child

Walker TM. et al, (2020), Wellcome Open Research, 5

Maturation of the Human Immunoglobulin Heavy Chain Repertoire With Age.

Ghraichy M. et al, (2020), Front Immunol, 11

Outcomes beyond hospital discharge in infants and children with viral meningitis: A systematic review.

Hudson JA. et al, (2019), Rev Med Virol

Load More

1
2
3
4
5
6

Include forthcoming?